grant

GLP In-Vivo Preclinical Safety and Pharmacokinetic Study of a Novel Dual-Drug Coated Balloon Formulation

Organization UKRILocation United Kingdom
UKRIUK ResearchGrantActive
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

CAD symptoms can include chest pain and shortness of breath. A complete blockage of blood flow can lead to a heart attack.

CAD and PAD are estimated to affect over 500m and 200m people around the world, respectively, and these numbers are increasing continuously.

Traditional treatments for CAD and PAD have included endovascular interventions…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
GLP In-Vivo Preclinical Safety and Pharmacokinetic Study of a Novel Dual-Drug Coated Balloon Formulation — UKRI | United | Dev Procure